Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
Anacor Pharmaceuticals, Inc. |
Mylan Pharmaceuticals Inc. and Mylan Inc. |
1:2019cv00632 |
April 4, 2019 |
US District Court for the District of Delaware |
Richard G Andrews |
Patent |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on June 26, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
|
|
Filing 63 STIPULATION TO EXTEND TIME Proposed Protective Order to and including June 27, 2019 - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
|
|
Filing 62 NOTICE OF SERVICE of (1) Anacor's Rule 26(a) Initial Disclosures and (2) Anacor's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) |
Filing 61 STIPULATION TO EXTEND TIME Deadline for the Parties to Submit a Proposed Protective Order to June 13, 2019 - filed by Perrigo Company plc, Perrigo Pharma International DAC. (Ovanesian, Michelle) |
Filing 60 NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and Mylan Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) and the District of Delaware's Default Standard for Discovery filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) |
|
Filing 58 Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Revised Proposed Scheduling Order. (Attachments: #1 Revised Proposed Scheduling Order)(Dellinger, Megan) |
Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 4/25/2019. Local counsel present for plaintiff: M. Dellinger. Local counsel present for defendants: P. Kraman, A. Gaza, K. Farnan, D. Moore, K. Mowery, N. Hoeschen, R. Touhey Myer, M. Haney, K. Harmon, K. Dorsney, S. Coyle. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(crb) |
Filing 57 Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Proposed Scheduling Order. (Attachments: #1 Proposed Order)(Dellinger, Megan) Modified on 4/24/2019 (nms). |
Filing 56 NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu) |
Filing 55 NOTICE of Appearance by David Ellis Moore on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Moore, David) |
Filing 54 Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 18, 2018. Date of Expiration of Patent: August 16, 2026. (Dellinger, Megan) |
|
|
Filing 51 NOTICE TO COUNSEL: MDL No. 1:2019-md-2884 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents may use the attached form to register for a CM/ECF login and password. Please see the docket for further entries. (nmg) |
Filing 50 Record of case transferred in from District of West Virginia Northern; Case Number in Other District: 1:18-cv-00202. Copy of Docket Sheet and original file |
|
Case transferred to District of Delaware re MDL 2884. Entire Case file electronically transmitted. (mh) [Transferred from West Virginia Northern on 4/4/2019.] |
NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. (nmg) |
|
Filing 47 PHV Filing fee on behalf of Yan-Xin Li; $ 200.00, receipt number WVNC002549 (mh) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 46 MOTION for Leave of Yan-Xin Li to Appear Pro Hac Vice, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(O'Brien, William) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 45 REPORT of Rule 26(f) Planning Meeting. (Attachments: #1 Attachment Parties proposals as to schedule)(Copland, Gordon) [Transferred from West Virginia Northern on 4/4/2019.] |
|
Filing 43 CERTIFICATE OF SERVICE by Anacor Pharmaceuticals, Inc. re Rule 26(a) Initial Disclosures (Companion, James) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 42 CERTIFICATE OF SERVICE by Mylan Inc., Mylan Pharmaceuticals Inc. for Defendants' Initial Disclosures Pursuant to Rule 26(a)(1). (O'Brien, William) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 41 Photocopy of The Mylan Defendants' Response to Anacor Pharmaceuticals, Inc.'s Motion to Transfer to District of Delaware. (Attachments: #1 Photocpy of Certificate of Service)(mh) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 40 Reply in Support re #25 Motion to Stay, filed by Anacor Pharmaceuticals, Inc.. (Companion, James) Modified on 2/5/2019 to correct entry to link to correct motion. NEF regen. (mh).[Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 39 RESPONSE to #25 MOTION to Stay, filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (O'Brien, William) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
|
Filing 37 MOTION to Continue Deadlines in First Order and Notice Regarding Discovery and Scheduling, by Anacor Pharmaceuticals, Inc.. (Companion, James) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
|
|
|
|
|
Filing 31 PHV Filing fee for Attorneys Hanson, Devine, Kong and Deshmukh: $ 800.00, receipt number WVNC002463. (mh) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 30 MOTION for Leave to Appear Pro Hac Vice Tung-On Kong, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(O'Brien, William) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 29 MOTION for Leave to Appear Pro Hac Vice Anjali D. Deshmukh, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(O'Brien, William) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 28 MOTION for Leave to Appear Pro Hac Vice Kristina M. Hanson, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(O'Brien, William) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 27 MOTION for Leave to Appear Pro Hac Vice Wendy Devine, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(O'Brien, William) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 26 MEMORANDUM In Support re #25 MOTION to Stay Case, by Anacor Pharmaceuticals, Inc.. (Companion, James) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 25 MOTION to Stay Case, by Anacor Pharmaceuticals, Inc.. (Companion, James) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 24 Copy of Motion for Transfer of Action to the District of Delaware Pursuant to 28 USC 1407 For Coordinated and Consolidated Pretrial Proceedings, filed before the United States Judicial Panel of Multidistrict Litigation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4 )(mh)[Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 23 Answer to #21 Answer to Complaint, and Counterclaim, filed by Anacor Pharmaceuticals, Inc.. (Companion, James) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 22 Corporate Disclosure Statement by Mylan Inc., Mylan Pharmaceuticals Inc. identifying Corporate Parent Mylan Inc., Corporate Parent Mylan N.V. for Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.; Corporate Parent Mylan N.V. for Mylan Inc., Mylan Inc... (O'Brien, William) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 21 ANSWER to #1 Complaint, , COUNTERCLAIM against Anacor Pharmaceuticals, Inc. by Mylan Pharmaceuticals Inc., Mylan Inc..(O'Brien, William) [Transferred from West Virginia Northern on 4/4/2019.] |
|
Filing 19 SUMMONS Returned Executed as to Mylan Pharmaceuticals Inc. served on 11/20/2018. (mh) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 18 SUMMONS Returned Executed as to Mylan Inc. served on 11/20/2018. (mh) [Transferred from West Virginia Northern on 4/4/2019.] |
|
|
|
|
Filing 11 PHV Filing fee: $ 800.00, receipt number WVNC002403 re: Attorneys Sheh, Maurer, Berl and Horniak. (mh) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 10 MOTION for Leave to Appear pro hac vice of Anthony Sheh, by Anacor Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A, #2 Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 9 MOTION for Leave to Appear pro hac vice of Aaron P. Maurer, by Anacor Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A, #2 Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 8 MOTION for Leave to Appear pro hac vice of David I. Berl, by Anacor Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A, #2 Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 7 MOTION for Leave to Appear pro hac vice of David M. Horniak, by Anacor Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A, #2 Text of Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 4/4/2019.] Modified on 4/4/2019 (nms). |
Filing 6 VERIFICATION OF ATTORNEY ADMISSION to Attorneys Maurer, Sheh, Horniak and Berl. (mh) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 5 Corporate Disclosure Statement by Anacor Pharmaceuticals, Inc. identifying Corporate Parent Pfizer Inc. for Anacor Pharmaceuticals, Inc. (mh) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 4 Filing fee: $ 400.00, receipt number WVNW002018 (mh) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 3 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint.(mh) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 2 Supplemental Information for Patent Cases Involving An Abbreviated New Drug Application (ANDA) filed by Anacor Pharmaceuticals, Inc. (mh) [Transferred from West Virginia Northern on 4/4/2019.] |
Filing 1 COMPLAINT against Mylan Inc. and Mylan Pharmaceuticals Inc., filed by Anacor Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A - Patent Information, #2 Exhibit B - Patent Information, #3 Exhibit C - Patent Information, #4 Exhibit D - Patent Information, #5 Civil Cover Sheet)(mh) [Transferred from West Virginia Northern on 4/4/2019.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.